{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:09:46Z","timestamp":1793711386850,"version":"4.6.1"},"reference-count":30,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["RA 3044\/6-1"],"award-info":[{"award-number":["RA 3044\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,30]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Liver transplantation remains the only curative option for end-stage liver disease, yet high waitlist mortality and organ scarcity continue to challenge the field. The randomised multicentre ExTra trial aims to decrease time-to-transplant by safely improving access to transplantation through viability assessment of otherwise discarded grafts with normothermic machine perfusion (NMP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The ExTra trial is a prospective, randomised, multicentre study conducted across German transplant centres. Participants listed for liver transplantation with a reMELD-Na-Score \u226421 (refitted MELD-Natrium Score)\u2009who are not eligible for Standard or Non-Standard Exceptions will be randomised for a 1-year intervention period into two groups: the experimental arm, in which they have\u2014in addition to regular organ allocation\u2014the extra option to receive a graft that was initially deemed non-transplantable based on clinical criteria, but meets specified quality criteria after at least 4\u2009hours of NMP, and the control arm, which consists of conventional allocation procedures alone. The primary endpoint is time-to-transplant, defined as the period between randomisation and transplantation. Secondary outcomes include competing events (death, disease progression or recovery without transplantation), graft and patient survival, quality of life and cost-effectiveness. Additional analyses will assess early graft function, length of hospital stay, biliary complications and 1-year post-transplant outcomes. A centralised biobank will collect perfusate, tissue and blood samples for biomarker research. Safety will be monitored through quarterly reviews by a Data Safety Monitoring Board.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol received approval from the Institutional Review Board of the Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin on 2 April 2025 (EA1\/04\/25). Participating study centres will need local Institutional Review Board approval prior to initiation. This study complies with Good Clinical Practice guidelines and all applicable national and local regulations. Results will be disseminated during international and national conference meetings and through publication in a peer-reviewed journal with open access.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06874296\">NCT06874296<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-114833","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:10:19Z","timestamp":1786619419000},"page":"e114833","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Open, prospective, randomised, multicentre trial on quality assessment of declined liver grafts by normothermic ex situ machine perfusion for decreasing time to transplantation (ExTra trial): a study protocol"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06874296","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06874296","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-4788","authenticated-orcid":false,"given":"Simon","family":"Moosburner","sequence":"first","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"BIH Biomedical Innovation Academy, BIH Charit\u00e9 Clinician Scientist Program, Berlin Institute of Health at Charit\u00e9\u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M G V","family":"Gassner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor M","family":"Sauer","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateja","family":"Mandac","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik P","family":"Modest","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Cancer Immunology, Charite - Universitatsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Zocholl","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Clinical Epidemiology, Charit\u00e9 - Universitatsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Stegherr","sequence":"additional","affiliation":[{"name":"Institute of Biometry and Clinical Epidemiology, Charit\u00e9 - Universitatsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar S","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Surgical Transplantation, The University of Texas Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wendon","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, School of Immunology and Microbial Sciences, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Selzner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Ajmera Transplant Centre, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pascher","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplant Surgery, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uli","family":"Fehrenbach","sequence":"additional","affiliation":[{"name":"Department of Radiology, Charite - Universitatsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Pratschke","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Raschzok","sequence":"additional","affiliation":[{"name":"Department of Surgery, Campus Charit\u00e9 Mitte | Campus Virchow-Klinikum, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Berlin, Germany"},{"name":"BIH Biomedical Innovation Academy, BIH Charit\u00e9 Clinician Scientist Program, Berlin Institute of Health at Charit\u00e9\u2013 Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026090400402154000_16.8.e114833.1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2015.08.021","article-title":"An update on liver transplantation: A critical review","volume":"66","author":"Neuberger","year":"2016","journal-title":"J Autoimmun"},{"key":"2026090400402154000_16.8.e114833.2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061929","article-title":"The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate","volume":"9","author":"Ritschl","year":"2020","journal-title":"J Clin Med"},{"key":"2026090400402154000_16.8.e114833.3","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1016\/j.jhep.2023.03.001","article-title":"How many liver grafts could be recovered after implementation of donation after cardiac death in Germany?","volume":"79","author":"Moosburner","year":"2023","journal-title":"J Hepatol"},{"key":"2026090400402154000_16.8.e114833.4","unstructured":"Organtranstplantation DS . Jahresbericht organspende und transplantation in deutschland 2023. 2024."},{"key":"2026090400402154000_16.8.e114833.5","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.914246"},{"key":"2026090400402154000_16.8.e114833.6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/lt.24805","article-title":"Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions","volume":"23","author":"Umgelter","year":"2017","journal-title":"Liver Transpl"},{"key":"2026090400402154000_16.8.e114833.7","unstructured":"Eurotransplant . Chapter 5 et liver allocation system (elas). In: Eurotransplant Manual. 2026."},{"key":"2026090400402154000_16.8.e114833.8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1055\/a-1199-7432","article-title":"Declined Liver Grafts - Analysis of the German Donor Population from 2010 to 2018","volume":"58","author":"Moosburner","year":"2020","journal-title":"Z Gastroenterol"},{"key":"2026090400402154000_16.8.e114833.9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/SLA.0000000000004198","article-title":"Making Every Liver Count: Increased Transplant Yield of Donor Livers Through Normothermic Machine Perfusion","volume":"272","author":"MacConmara","year":"2020","journal-title":"Ann Surg"},{"key":"2026090400402154000_16.8.e114833.10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/lt.24461","article-title":"Liver transplantation in Germany","volume":"22","author":"Tacke","year":"2016","journal-title":"Liver Transpl"},{"key":"2026090400402154000_16.8.e114833.11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SLA.0000000000006491","article-title":"Multinational Analysis of Marginal Liver Grafts Based on the Eurotransplant Extended Donor Criteria","volume":"280","author":"Moosburner","year":"2024","journal-title":"Ann Surg"},{"key":"2026090400402154000_16.8.e114833.12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamasurg.2017.5040","article-title":"Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model","volume":"153","author":"Agopian","year":"2018","journal-title":"JAMA Surg"},{"key":"2026090400402154000_16.8.e114833.13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jhep.2020.12.009","article-title":"L-GrAFT and EASE scores in liver transplantation: Need for reciprocal external validation and comparison with other scores","volume":"75","author":"Avolio","year":"2021","journal-title":"J Hepatol"},{"key":"2026090400402154000_16.8.e114833.14","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22091"},{"key":"2026090400402154000_16.8.e114833.15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","article-title":"Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era","volume":"254","author":"Dutkowski","year":"2011","journal-title":"Ann Surg"},{"key":"2026090400402154000_16.8.e114833.16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhep.2024.06.035","article-title":"Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study)","volume":"82","author":"Eden","year":"2025","journal-title":"J Hepatol"},{"key":"2026090400402154000_16.8.e114833.17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2025.01.042","article-title":"Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant Association","volume":"82","author":"Hessheimer","year":"2025","journal-title":"J Hepatol"},{"key":"2026090400402154000_16.8.e114833.18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00423-020-02014-7","article-title":"Ex vivo machine perfusion: current applications and future directions in liver transplantation","volume":"406","author":"Michelotto","year":"2021","journal-title":"Langenbecks Arch Surg"},{"key":"2026090400402154000_16.8.e114833.19","doi-asserted-by":"crossref","unstructured":"Boerger L , Hillebrandt KH , Czigany Z , et al . Ex Vivo Liver Machine Perfusion Reduces the Length of Hospital Stay in Recipients of Allografts from Elderly Donors: A Systematic Review. Advanced Therapeutics 2023;6. doi:10.1002\/adtp.202200291","DOI":"10.1002\/adtp.202200291"},{"key":"2026090400402154000_16.8.e114833.20","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/ajt.13875","article-title":"Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation","volume":"16","author":"Mergental","year":"2016","journal-title":"Am J Transplant"},{"key":"2026090400402154000_16.8.e114833.21","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16251-3","article-title":"Transplantation of discarded livers following viability testing with normothermic machine perfusion","volume":"11","author":"Mergental","year":"2020","journal-title":"Nat Commun"},{"key":"2026090400402154000_16.8.e114833.22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","article-title":"Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial","volume":"270","author":"van Leeuwen","year":"2019","journal-title":"Ann Surg"},{"key":"2026090400402154000_16.8.e114833.23","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/lt.25850","article-title":"Assessment and Transplantation of Orphan Donor Livers: A Back-to-Base Approach to Normothermic Machine Perfusion","volume":"26","author":"Reiling","year":"2020","journal-title":"Liver Transpl"},{"key":"2026090400402154000_16.8.e114833.24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.surg.2021.10.056","article-title":"Transplantation of declined livers after normothermic perfusion","volume":"171","author":"Quintini","year":"2022","journal-title":"Surgery"},{"key":"2026090400402154000_16.8.e114833.25","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/ajt.17022","article-title":"Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers","volume":"22","author":"van Leeuwen","year":"2022","journal-title":"Am J Transplant"},{"key":"2026090400402154000_16.8.e114833.26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/XCS.0000000000000555","article-title":"Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation","volume":"236","author":"Olumba","year":"2023","journal-title":"J Am Coll Surg"},{"key":"2026090400402154000_16.8.e114833.27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/aor.14936","article-title":"Sequential Hypothermic and Normothermic Machine Perfusion of Extended Criteria Donors in Liver Transplantation: A Single-Center Preliminary Experience","volume":"49","author":"Magistri","year":"2025","journal-title":"Artif Organs"},{"key":"2026090400402154000_16.8.e114833.28","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.4095","article-title":"Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant","volume":"155","author":"Avolio","year":"2020","journal-title":"JAMA Surg"},{"key":"2026090400402154000_16.8.e114833.29","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181b13ca2"},{"key":"2026090400402154000_16.8.e114833.30","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318296c732"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-114833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:40:38Z","timestamp":1788507638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-114833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,13]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2025-114833"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-114833","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}